Immunomic Therapeutics
Updated: October 28, 2025
CEO William G. Hearl
Country: USA | Funding: $84.9M (+)
Website: https://www.immunomix.com
Immunomic Therapeutics is a development stage biotechnology company that develops lysosomal associated membrane protein-based vaccines.
Website: https://www.immunomix.com
Immunomic Therapeutics is a development stage biotechnology company that develops lysosomal associated membrane protein-based vaccines.
